Funding for collaborative research projects between network partners The national network for breast cancer research announce 600 000 NOK in research funding for new ideas and pilot studies within the network.
Network meeting at Thorbjørnrud Exciting reaserch results, new possibility for collaboration, and a grate visit to Hadeland glassverk.
ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
SATT: Secondary Adjuvant (rescue) Treatment with docetaxel (Taxotere) and detection of isolated tumor cells in bone marrow as a surrogate marker for effect in node positive and high risk node negative breast cancer after standard
